What can we help you with?

Services Phases

Services

Non-Covalent Binding AssaysNon-Covalent Binding AssaysCovalent Binding AssaysCovalent Binding AssaysProteomics & ChemoproteomicsProteomics & ChemoproteomicsSmall Molecule AnalysisSmall Molecule AnalysisOligo AnalysisOligo AnalysisData ProductsData ProductsView All ServicesView All Services

Phases

Target Discovery & ValidationTarget Discovery & ValidationLead GenerationLead GenerationLead Selection & OptimizationLead Selection & OptimizationPreclinical StudiesPreclinical StudiesBiomarker Discovery, Development & AnalysisBiomarker Discovery, Development & AnalysisView All PhasesView All Phases

What can we help you with?

Modalities Therapeutic Areas

Modalities

RadiotherapeuticsRadiotherapeuticsMolecular GluesMolecular GluesTargeted DegradersTargeted DegradersCovalent DrugsCovalent DrugsDNA- and RNA-Targeting DrugsDNA- and RNA-Targeting DrugsOligonucleotide TherapeuticsOligonucleotide TherapeuticsKinase InhibitorsKinase InhibitorsView All ModalitiesView All Modalities

Therapeutic Areas

OncologyOncologyImmunologyImmunologyNeuroscienceNeuroscienceMetabolic DiseaseMetabolic DiseaseInfectious DiseaseInfectious DiseaseRare DiseasesRare DiseasesView All Therapeutic AreasView All Therapeutic Areas

What can we help you with?

TechnologiesOmicscouts Platforms Expertise

TechnologiesOmicscouts

ProteomeScout™ProteomeScout™PlasmaScout™PlasmaScout™QuantScout™QuantScout™TurnoverScout™TurnoverScout™Protein Turnover Atlas™Protein Turnover Atlas™SignalingScout™SignalingScout™UbiScout™UbiScout™DecryptMDecryptMTargetScout™TargetScout™PhotoTargetScout™PhotoTargetScout™KinomeScout™KinomeScout™CysScout™CysScout™SideScout™SideScout™NucleoBeads™NucleoBeads™SurfaceScout™SurfaceScout™View All TechnologiesView All Technologies

Platforms

RapidFire-MSRapidFire-MSICP-MSICP-MSOrbitrap Astral ZoomOrbitrap Astral ZoomOrbitrap AscendOrbitrap AscendView All PlatformsView All Platforms

Expertise

Project ManagementProject ManagementCompound Management & Chemical LibrariesCompound Management & Chemical LibrariesScreening LaboratoryScreening LaboratoryBiochemistry & Chemical BiologyBiochemistry & Chemical BiologyCell & Molecular BiologyCell & Molecular BiologyMS-based ProteomicsMS-based ProteomicsComputational BiologyComputational BiologyView All ExpertiseView All Areas of Expertise

News & Events

May 28, 2025
•SAB

Billerica, MA and Freising, Germany

Momentum Biotechnologies Expands Scientific Advisory Board with Two New Additions

Momentum Biotechnologies ("Momentum"), a contract research organization specializing in mass spectrometry-based drug discovery and proteomics, announced today the appointment of two new members to its Scientific Advisory Board ("SAB"): Dr. Bernhard Küster and Dr. Mathias Wilhelm. Both are professors at the Technical University of Munich ("TUM") and co-founders of OmicScouts, a proteomics service provider recently acquired by Momentum (now operating as OmicScouts, A Momentum Biotechnologies Company). "We are proud to add these two renowned scientists to our scientific advisory board," says...
March 4, 2025
•Acquisition

Billerica, MA and Freising, Germany

Momentum Biotechnologies Announces Acquisition of OmicScouts

https://vimeo.com/1071860408 Momentum Biotechnologies (“Momentum”), a contract research organization (“CRO”) specializing in mass spectrometry-based drug discovery, announced today that it has successfully completed the acquisition of OmicScouts GmbH (“OmicScouts”), a Munich-based CRO and established leader in the field of mass spectrometry-based proteomics, operating hereafter as OmicScouts, a Momentum Biotechnologies Company. With this transaction, Momentum gains access to a broad portfolio of well-validated proteomic assays that enhance and extend their existing service offerings,...

Sort By

Filter By

Sign up for News & Updates